R.H. Bluestein & Co’s Cavium, Inc. CAVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-3,000
| Closed | -$260K | – | 336 |
|
|
2018
Q2 | $260K | Hold |
3,000
| – | – | 0.01% | 266 |
|
|
2018
Q1 | $238K | Hold |
3,000
| – | – | 0.01% | 288 |
|
|
2017
Q4 | $251K | Buy |
+3,000
| New | +$232K | 0.01% | 280 |
|
|
2017
Q2 | – | Sell |
-3,000
| Closed | -$215K | – | 351 |
|
|
2017
Q1 | $215K | Buy |
+3,000
| New | +$201K | 0.01% | 295 |
|
|
2016
Q1 | – | Sell |
-5,000
| Closed | -$329K | – | 324 |
|
|
2015
Q4 | $329K | Hold |
5,000
| – | – | 0.02% | 197 |
|
|
2015
Q3 | $307K | Hold |
5,000
| – | – | 0.02% | 222 |
|
|
2015
Q2 | $344K | Hold |
5,000
| – | – | 0.02% | 236 |
|
|
2015
Q1 | $354K | Hold |
5,000
| – | – | 0.02% | 230 |
|
|
2014
Q4 | $309K | Hold |
5,000
| – | – | 0.02% | 272 |
|
|
2014
Q3 | $249K | Hold |
5,000
| – | – | 0.02% | 318 |
|
|
2014
Q2 | $248K | Hold |
5,000
| – | – | 0.01% | 316 |
|
|
2014
Q1 | $219K | Buy |
+5,000
| New | +$196K | 0.01% | 323 |
|
|
2013
Q4 | – | Sell |
-5,000
| Closed | -$206K | – | 386 |
|
|
2013
Q3 | $206K | Buy |
+5,000
| New | +$188K | 0.01% | 316 |
|
R.H. Bluestein & Co's CAVM Position: Q3 2018 in Review
R.H. Bluestein & Co sold out of Cavium, Inc. (CAVM) in Q3 2018, closing a stake of 3,000 shares — an estimated $260K sold.
R.H. Bluestein & Co first reported a position in CAVM in Q3 2013 and held it in 13 quarters. The position peaked at $354K in Q1 2015. 0 funds tracked by Wall St. Rank hold CAVM as of Q3 2018.
- R.H. Bluestein & Co reported no remaining Cavium, Inc. position as of Q3 2018 after selling out during the quarter.
- R.H. Bluestein & Co sold 3,000 Cavium, Inc. shares in Q3 2018, an estimated $260K.
- R.H. Bluestein & Co first reported a position in Cavium, Inc. in Q3 2013 and held it in 13 quarters.
- R.H. Bluestein & Co's Cavium, Inc. position peaked at $354K in Q1 2015.
- 0 funds tracked by Wall St. Rank held Cavium, Inc. as of Q3 2018.
Based on R.H. Bluestein & Co's 13F filing for Q3 2018, filed 13 Nov 2018.